Table 3: Comparison of FMF with amyloidosis, amyloidosis-free FMF, and controls in terms of leucocyte, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and neutrophil/lymphocyte ratio (NLR) values.

FMF with amyloidosis
(mean ± SD)
FMF without amyloidosis
(mean ± SD)
Controls
(mean ± SD)

Leucocyte, ×109/L8.35 ± 2.587.19 ± 1.756.81 ± 1.430.0840.0680.158
ESR, mm/h24.00 ± 15.899.83 ± 8.426.40 ± 4.13<0.00010.0160.006
CRP, mg/L4.42 ± 2.243.04 ± 2.082.43 ± 1.570.1910.0590.090
NLR, %2.51 ± 0.621.99 ± 0.581.59 ± 0.420.009<0.0001<0.0001

: value comparison between FMF with amyloidosis and FMF without amyloidosis.
: value comparison between FMF with amyloidosis and healthy controls.
: value comparison between FMF without amyloidosis and healthy controls.